Hemoglobin A 1c as a screen for previously undiagnosed prediabetes and diabetes in an acute-care setting

Diabetes Care

Volumn 34, Issue 9, 2011, Pages 1908-1912

  Silverman, Robert A ^a,b   Thakker, Urvi ^a   Ellman, Tovah ^a   Wong, Ivan ^a   Smith, Kelly ^a   Ito, Kazuhiko ^c   Graff, Kirsten ^a  

^a LONG ISLAND JEWISH MEDICAL CENTER   (United States)

^b FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

^c NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; GLYCOSYLATED HEMOGLOBIN;

ACUTE DISEASE; ADULT; ARTICLE; CLINICAL TRIAL; DIABETES MELLITUS; DIAGNOSTIC TEST ACCURACY STUDY; EMERGENCY WARD; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HUMAN; IMPAIRED GLUCOSE TOLERANCE; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; ORAL GLUCOSE TOLERANCE TEST; OUTPATIENT; PREDICTIVE VALUE; PREVALENCE; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; SCREENING; SENSITIVITY AND SPECIFICITY; BLOOD; DIET RESTRICTION; GLUCOSE TOLERANCE TEST; METABOLISM; MIDDLE AGED;

ADULT; BLOOD GLUCOSE; DIABETES MELLITUS; FASTING; FEMALE; GLUCOSE TOLERANCE TEST; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; PREDIABETIC STATE;

EID: 84856223080     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc10-0996     Document Type: Article

References (25)

1. Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 2010;87:4-14
2. Koopman RJ, Mainous AG 3rd, Liszka HA, et al. Evidence of nephropathy and peripheral neuropathy in US adults with undiagnosed diabetes. Ann Fam Med 2006; 4:427-432 (Pubitemid 44544149)
3. Spijkerman AM, Dekker JM, Nijpels G, et al. Microvascular complications at time of diagnosis of type 2 diabetes are similar among diabetic patients detected by targeted screening and patients newly diagnosed in general practice: the hoorn screening study. Diabetes Care 2003;26: 2604-2608 (Pubitemid 37052107)
4. Centers for Disease Control and Prevention. National diabetes fact sheet: national estimates and general information on diabetes and prediabetes in the United States, 2011. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, 2011. Available at www.cdc.gov/diabetes/pubs/pdf/nfs 2011.pdf. Accessed 4 July 2011
5. Knowler WC, Barrett-Connor E, Fowler SE, et al.; Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002;346:393-403 (Pubitemid 34437694)
6. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2010;33(Suppl. 1):S62-S69
7. 1c in predicting progression to diabetes in French men and women: data from an Epidemiological Study on the Insulin Resistance Syndrome (DESIR). Diabetes Care 2006; 29:1619-1625
8. Edelman D, Olsen MK, Dudley TK, Harris AC, Oddone EZ. Utility of hemoglobin A1C in predicting diabetes risk. J Gen Intern Med 2004;19:1175-1180 (Pubitemid 40041381)
9. 1c predicts diabetes but not cardiovascular disease in nondiabetic women. Am J Med 2007;120: 720-727
10. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2006;29(Suppl. 1):S43-S48
11. Mohan V, Vijayachandrika V, Gokulakrishnan K, et al. A1C cut points to define various glucose intolerance groups in Asian Indians. Diabetes Care 2010;33:515-519
12. Hu Y, Liu W, Chen Y, et al. Combined use of fasting plasma glucose and glycated hemoglobin A1C in the screening of diabetes and impaired glucose tolerance. Acta Diabetol 2010;47:231-236
13. 1cpredicts the likelihood of having impaired glucose tolerance in high-risk patients with normal fasting plasma glucose. Ann Clin Biochem 2005;42:193-195
14. Cheng YJ, Gregg EW, Geiss LS, et al. Association of A1C and fasting plasma glucose levels with diabetic retinopathy prevalence in the U.S. population: implications for diabetes diagnostic thresholds. Diabetes Care 2009;32:2027-2032
15. Miyazaki M, Kubo M, Kiyohara Y, et al.; Hisayama Study. Comparison of diagnostic-methods for diabetes mellitus based on prevalence of retinopathy in a Japanese population: the Hisayama Study. Diabetologia 2004;47:1411-1415 (Pubitemid 39232427)
16. van 't Riet E, Alssema M, Rijkelijkhuizen JM, Kostense PJ, Nijpels G, Dekker JM. Relationship between A1C and glucose levels in the general Dutch population: the new Hoorn Study. Diabetes Care 2010; 33:61-66
17. 1c) in screening for undiagnosed diabetes in the U.S. population. Diabetes Care 2000;23:187-191
18. 1cin screening for undiagnosed diabetes in the US population. J Gen Intern Med 2008;23:1346-1353
19. 1c measurement improves the detection of type 2 diabetes in high-risk individuals with nondiagnostic levels of fasting plasma glucose: the Early Diabetes Intervention Program (EDIP). Diabetes Care 2001;24:465-471
20. Jesudason DR, Dunstan K, Leong D, Wittert GA. Macrovascular risk and diagnostic criteria for type 2 diabetes: implications for the use of FPG and HbA1cfor cost-effective screening. Diabetes Care 2003;26:485-490 (Pubitemid 36929079)
21. Pitts SR, Niska RW, Xu J, Burt CW. National Hospital Ambulatory Medical Care Survey: 2006 emergency department summary. Natl Health Stat Report 2008; 7:1-38
22. Cowie CC, Rust KF, Byrd-Holt DD, et al. Prevalence of diabetes and high risk for diabetes using A1C criteria in the U.S. population in 1988-2006. Diabetes Care 2010;33:562-568
23. Mazurek JA, Hailpern SM, Goring T, Nordin C. Prevalence of hemoglobin A1c greater than 6.5% and 7.0% among hospitalized patients without known diagnosis of diabetes at an urban inner city hospital. J Clin Endocrinol Metab 2010; 95:1344-1348
24. McBride CM, Emmons KM, Lipkus IM. Understanding the potential of teachable moments: the case of smoking cessation. Health Educ Res 2003;18:156-170 (Pubitemid 36457244)
25. Gorin AA, Phelan S, Hill JO, Wing RR. Medical triggers are associated with better short- and long-term weight loss outcomes. Prev Med 2004;39:612-616 (Pubitemid 39093918)